Molecular response in CML: where is the bar?

Por Baccarani, Michele, Soverini, Simona
Publicado em 2014

Treatment and monitoring of Philadelphia chromosome-positive leukemia patients: recent advances and remaining challenges

Por Simona Soverini, Renato Bassan, Thomas Lion
Publicado em 2019-04-01

Best Practices in Chronic Myeloid Leukemia Monitoring and Management

Por Soverini, Simona, De Benedittis, Caterina, Mancini, Manuela, Martinelli, Giovanni
Publicado no Oncologist (2016)

Choosing the Best Second-Line Tyrosine Kinase Inhibitor in Imatinib-Resistant Chronic Myeloid Leukemia Patients Harboring Bcr-Abl Kinase Domain Mutations: How Reliable Is the IC(50...

Por Soverini, Simona, Rosti, Gianantonio, Iacobucci, Ilaria, Baccarani, Michele, Martinelli, Giovanni
Publicado em 2011

Do the human gut metagenomic species possess the minimal set of core functionalities necessary for life?

Por Matteo Soverini, Simone Rampelli, Silvia Turroni, Patrizia Brigidi, Elena Biagi, Marco Candela
Publicado em 2020-09-01

HumanMycobiomeScan: a new bioinformatics tool for the characterization of the fungal fraction in metagenomic samples

Por Matteo Soverini, Silvia Turroni, Elena Biagi, Patrizia Brigidi, Marco Candela, Simone Rampelli
Publicado em 2019-06-01

Aurora kinase inhibitors: which role in the treatment of chronic myelogenous leukemia patients resistant to imatinib?

Por Martinelli, Giovanni, Papayannidis, Cristina, Iacobucci, Ilaria, Soverini, Simona, Cilloni, Daniela, Baccarani, Michele
Publicado em 2009

Pilot study on the additive effects of berberine and oral type 2 diabetes agents for patients with suboptimal glycemic control

Por Di Pierro, Francesco, Villanova, Nicola, Agostini, Federica, Marzocchi, Rebecca, Soverini, Valentina, Marchesini, Giulio
Publicado em 2012

c-Abl and Src-family kinases cross-talk in regulation of myeloid cell migration

Por Baruzzi, Anna, Iacobucci, Ilaria, Soverini, Simona, Lowell, Clifford A., Martinelli, Giovanni, Berton, Giorgio
Publicado no FEBS Lett (2010)

Nilotinib: a novel encouraging therapeutic option for chronic myeloid leukemia patients with imatinib resistance or intolerance

Por Martinelli, Giovanni, Iacobucci, Ilaria, Soverini, Simona, Palandri, Francesca, Castagnetti, Fausto, Rosti, Gianantonio, Baccarani, Michele
Publicado em 2007

ViromeScan: a new tool for metagenomic viral community profiling

Por Rampelli, Simone, Soverini, Matteo, Turroni, Silvia, Quercia, Sara, Biagi, Elena, Brigidi, Patrizia, Candela, Marco
Publicado no BMC Genomics (2016)

Variation of Carbohydrate-Active Enzyme Patterns in the Gut Microbiota of Italian Healthy Subjects and Type 2 Diabetes Patients

Por Soverini, Matteo, Turroni, Silvia, Biagi, Elena, Quercia, Sara, Brigidi, Patrizia, Candela, Marco, Rampelli, Simone
Publicado no Front Microbiol (2017)

CDC20 in and out of mitosis: a prognostic factor and therapeutic target in hematological malignancies

Por Samantha Bruno, Andrea Ghelli Luserna di Rorà, Roberta Napolitano, Simona Soverini, Giovanni Martinelli, Giorgia Simonetti
Publicado em 2022-04-01

Ponatinib as a Valid Alternative Strategy in Patients with Blast Crisis-Chronic Myeloid Leukemia Not Eligible for Allogeneic Stem Cells Transplantation and/or Conventional Chemothe...

Por Bucelli, Cristina, Cattaneo, Daniele, Ferla, Valeria, Zappa, Manuela, de Benedittis, Caterina, Soverini, Simona, Iurlo, Alessandra
Publicado no Case Rep Hematol (2017)

Characterization of 46 patient-specific BCR-ABL1 fusions and detection of SNPs upstream and downstream the breakpoints in chronic myeloid leukemia using next generation sequencing

Por Linhartova, Jana, Hovorkova, Lenka, Soverini, Simona, Benesova, Adela, Jaruskova, Monika, Klamova, Hana, Zuna, Jan, Machova Polakova, Katerina
Publicado no Mol Cancer (2015)

Chibby 1: a new component of β-catenin-signaling in chronic myeloid leukemia

Por Mancini, Manuela, Soverini, Simona, Gugliotta, Gabriele, Santucci, Maria Alessandra, Rosti, Gianantonio, Cavo, Michele, Martinelli, Giovanni, Castagnetti, Fausto
Publicado no Oncotarget (2017)

BCR-ABL1-Associated Reduction of Beta Catenin Antagonist Chibby1 in Chronic Myeloid Leukemia

Por Leo, Elisa, Mancini, Manuela, Aluigi, Michela, Luatti, Simona, Castagnetti, Fausto, Testoni, Nicoletta, Soverini, Simona, Santucci, Maria Alessandra, Martinelli, Giovanni
Publicado em 2013

Variations in the Post-weaning Human Gut Metagenome Profile As Result of Bifidobacterium Acquisition in the Western Microbiome

Por Soverini, Matteo, Rampelli, Simone, Turroni, Silvia, Schnorr, Stephanie L., Quercia, Sara, Castagnetti, Andrea, Biagi, Elena, Brigidi, Patrizia, Candela, Marco
Publicado no Front Microbiol (2016)

Pancreatic enzyme elevation in chronic myeloid leukemia patients treated with nilotinib after imatinib failure

Por Palandri, Francesca, Castagnetti, Fausto, Soverini, Simona, Poerio, Angela, Gugliotta, Gabriele, Luatti, Simona, Amabile, Marilina, Martinelli, Giovanni, Rosti, Gianantonio, Baccarani, Michele
Publicado em 2009

Serum Total Tryptase Level Confirms Itself as a More Reliable Marker of Mast Cells Burden in Mast Cell Leukaemia (Aleukaemic Variant)

Por P. Savini, M. Rondoni, G. Poletti, A. Lanzi, O. Quercia, S. Soverini, C. De Benedittis, G. Musardo, G. Martinelli, G. F. Stefanini
Publicado em 2015-01-01